جست‌وجوی استاد و پژوهشگر

David Ericksonمشاهده پروفایل

استاد

• Global Health Technology
• Medical Diagnostics
• Microfluidics
• +۵ مورد دیگر

David Erickson is the SC Thomas Sze Director and Sibley College Professor at Cornell University's Sibley School of Mechanical and Aerospace Engineering. He also holds a joint professorship in the Division of Nutritional Sciences. His research focuses on global health technologies, medical diagnostics, microfluidics, photonics, nanotechnology, and energy systems. He previously served as Associate Dean of Engineering for Research and Graduate Programs. Erickson leads the NIH-funded PORTENT Center for Point-of-Care Technologies in Global Health and has co-founded companies like Dimensional Energy and VitaScan to commercialize diagnostic and energy technologies. Education: B.Sc., Mechanical Engineering, University of Alberta (1999) M.A.Sc., Mechanical Engineering, University of Toronto (2001) Ph.D., Mechanical Engineering, University of Toronto (2004) Postdoctoral Scholar, Electrical Engineering, California Institute of Technology (2005) Research Interests: Erickson’s work spans global health diagnostics , nanobio applications , and clean energy innovation . He develops portable medical devices for low-resource settings, including smartphone-integrated diagnostic tools for malaria, iron deficiency, and cancer. His lab also pioneers photothermal reactors for CO2 conversion into sustainable fuels. Key areas include: Point-of-care testing for infectious diseases and nutritional deficiencies Nanofluidic and optofluidic technologies for biomolecular analysis Solar-driven energy systems for carbon-neutral fuels Awards: Presidential Early Career Award for Scientists and Engineers (2011) Fellowships from the Optical Society, ASME, and Canadian Academy of Engineering Carbon X-Prize Finalist (2019) for Dimensional Energy’s CO2-to-fuel technology Grants & Industry Collaboration: Erickson’s research is funded by NIH, NSF, ARPA-E, DOE, and USAID. His lab’s innovations have spun off start-ups addressing global health and energy challenges. Notable projects include: - Portable cancer diagnostics in sub-Saharan Africa using mobile phone-based systems - Solar-powered CO2 conversion reactors tested in Wyoming and Arizona Labs & Teams: The Erickson Lab collaborates with the Cornell Atkinson Center for Sustainability and the McGovern Center for Entrepreneurship. Key initiatives include the PORTENT Center and the Dimensional Energy CO2-to-fuel project.

Wengong Jinمشاهده پروفایل

استادیار

• AI for drug discovery
• Generative AI models
• Geometric deep learning
• +۵ مورد دیگر

Wengong Jin is an Assistant Professor at the Khoury College of Computer Sciences, Northeastern University, and a visiting research scientist at the Eric and Wendy Schmidt Center at the Broad Institute. He holds a PhD from MIT CSAIL, advised by Prof. Regina Barzilay and Prof. Tommi Jaakkola. Research Interests: His work focuses on geometric and generative AI models for drug discovery, biology, and chemical engineering. Key areas include equivariant neural networks (e.g., FAFormer), diffusion models for binding energy prediction, antibody/enzyme design (RefineGNN, SurfPro), and molecular design through graph neural networks (Junction Tree VAE). He also explores domain generalization and systems for autonomous molecular discovery. Publications: His research has been published in top venues like NeurIPS, ICLR, ICML, Nature, Science, and Cell. Recent breakthroughs include discovering novel antibiotics using explainable AI and designing synergistic drug combinations for cancer treatment. Awards: He has received the BroadIgnite Award, Dimitris N. Chorafas Prize, and MIT EECS Outstanding Thesis Award for his contributions to computational biology and AI-driven drug discovery. Teaching: Currently teaches a PhD seminar on AI for Science, focusing on integrating machine learning into scientific discovery processes.

• Biomaterials
• Tissue Engineering
• Regenerative Medicine
• +۱۲ مورد دیگر

Professor Hala Zreiqat AM is a leading biomedical engineer at The University of Sydney , serving as the Director of the ARC Training Centre for Innovative BioEngineering . A Fellow of all major Australian academies (AAS, ATSE, FAHMS, FRSN), she develops 3D printed bioceramics for bone regeneration while championing diversity through initiatives like the IDEAL Society and BIOTech Futures mentorship program. Her work bridges academia, clinical practice, and industry in musculoskeletal research . Research Focus: Her lab creates synthetic bone scaffolds that mimic natural bone architecture, strength, and porosity, enabling non-rejected bone regeneration via patient-matched implants. Key applications include orthopaedic, dental, and maxillofacial repair , with over $18M in competitive funding and multiple patents. Current projects explore AI-driven scaffold performance prediction and anti-senescence strategies for aging-related bone loss. Scientific Trends: Recent publications highlight 3D printed nanovoxelated ceramics , antisenescence biomaterials , and multifunctional theranostic platforms . Her team integrates machine learning for scaffold design, atom probe tomography for interface analysis, and two-photon imaging for cellular monitoring in 3D environments. 2021-2022 Fulbright Senior Scholar 2018 NSW Premier's Woman of the Year 2019 Eureka Prize for Innovative Use of Technology Fellow of Australian Academy of Science (2021) Over $18M in research funding Teaching & Leadership: She designed core courses like Tissue Engineering and Nanomaterials in Medicine , mentoring 158 students in 2020 alone. As Chair of CAAR (2020-2023), she strengthens Australia-Arab collaborations. Her lab trains early-career researchers , with alumni now in academia and industry.

• Intellectual Property Law
• Competition Law
• Regulatory Law
• +۴ مورد دیگر

Timo Minssen is Professor of Law at the University of Copenhagen (UCPH) and the Founding Director of UCPH's Center for Advanced Studies in Bioscience Innovation Law (CeBIL). He also holds affiliations as an LML Research Affiliate at the University of Cambridge and an Inter-CeBIL Research Affiliate at Harvard Law School's Petrie-Flom Centre. With extensive expertise in Intellectual Property, Competition, and Regulatory Law, Minssen focuses on the legal aspects of emerging health and life science technologies, including genome editing, big data, artificial intelligence, and quantum technology. His educational background includes a German law degree (Staatsexamen) from Georg-August-University in Göttingen, and Swedish biotech & IPR related LL.M., LL.Lic., and LL.D. degrees from Lund University and Uppsala University. His PhD thesis on the patentability of biopharmaceutical technology in the US & Europe received the prestigious Swedish King Oscar award. 2024: TUM Global Visiting Professor, Technical University of Munich (Germany) 2016: Visiting Research Fellow, University of Cambridge (UK) 2014: Visiting Research Fellow, University of Oxford (UK) 2013-14: Visiting Scholar, Harvard Law School (US) 2012: LL.D. - Doctor of Laws (Swedish "juris doktor"), EU/US patent law, Lund University, Sweden Minssen's research spans AI & Big Data in Health & Life Sciences, Sustainable and responsible innovation & tech transfer, Pharmaceutical-, Life Science- & Biotech Law, Comparative European & US Patent Law, Intellectual Property Law & Open Innovation, and EU Competition- & US Antitrust Law. His work addresses legal issues throughout the lifecycle of health and life science products and processes, from R&D regulation to technology transfer and commercialization. His extensive publication record includes 7 books and over 200 articles and book chapters published in leading journals such as Science, Nature Biotechnology, JAMA, and Harvard Business Review. His research has been featured in The Economist, Financial Times, and other major media outlets. Minssen's recent work shows a strong focus on AI regulation, quantum technology law, and data governance in health contexts, reflecting the evolving landscape of technology and law. Scientific Awards and Recognition King Oscar award for best Jur. Dr. thesis (2014) Jorcks Fonds Forsknings Pris (Jorck's Foundation Research Prize) (2017) Awapatent Research Prize (2009) Max Planck Research Scholarship (2005) Visiting Scholar appointments at Harvard Law School, University of Oxford, and University of Cambridge Recipient of a Novo Nordisk Foundation Grant for a "Collaborative Research Program in Biomedical Innovation Law" (2018) As an advisor, Minssen serves international organizations including the WHO, WIPO, and EU Commission. He has supervised numerous PhD students in areas including pharmaceutical law, biotechnology patents, and antimicrobial resistance. His current research projects include the Novo Nordisk Foundation's International Collaborative Bioscience Innovation & Law (Inter-CeBIL) Programme (50 million DKK), CLASSICA: EU Horizon Project on AI-assisted surgery, and AI@Care: Law and Ethics and Algorithmic Bias in Healthcare. Minssen leads the Center for Advanced Studies in Bioscience Innovation Law (CeBIL), which serves as a hub for interdisciplinary research on the intersection of law, technology, and innovation in the health and life sciences. The center collaborates with institutions worldwide to address pressing legal challenges in emerging technologies.

Alexandre Marquesمشاهده پروفایل

استادیار

• Microbiology
• Immunology
• Parasitology
• +۶ مورد دیگر

Dr. Alexandre Marques is an Assistant Professor at the University of Southern Mississippi. His expertise spans Microbiology, Immunology, and Parasitology, with a focus on vaccine development against parasitic infections like Leishmaniasis, Chagas disease, and Malaria. He holds a PhD from the Universidade de São Paulo (2007) and teaches courses such as Gen Microbiology and Microorg Hth Di at the university. His research integrates immunological, clinical, and molecular approaches to understand parasitic disease mechanisms and therapeutic interventions. Notable areas include α-Gal immunization strategies, transcriptomic analysis of breast cancer, and vaccine design against Leishmania. He has also explored applications in aquaculture nutrition and cosmetic safety assessments. Dr. Marques’ work spans interdisciplinary collaborations, including veterinary medicine, nanotechnology-based drug delivery, and antimicrobial stewardship in pediatrics. His contributions to animal models for Chagas disease and canine visceral leishmaniasis highlight translational research impact. Key themes in his publications include immune response modulation, pathogen-host interactions, and biomarker discovery in chronic infections. He has published over 50 articles across microbiology, immunology, and biomedical engineering since 2007.

• Biomaterials
• Tissue Engineering
• Regenerative Medicine
• +۵ مورد دیگر

João F. Mano is a Full Professor at the Department of Chemistry, University of Aveiro, and Director of the Doctoral Program on Biotechnology. He leads the COMPASS Research Group and serves as Vice-Director at CICECO - Aveiro Institute of Materials. His academic appointments include Invited Professor at University of Lorraine (France), Visiting Professor at KAIST (South Korea), and Adjunct Professor at Ajou University (South Korea). Education: PhD in Chemistry (1996, Technical University of Lisbon); D.Sc. in Tissue Engineering, Regenerative Medicine and Stem Cells (2012, University of Minho) Research Interests focus on Biomaterials for Regenerative Medicine , integrating Nanotechnology , Microtechnology , and Biofabrication . His group develops Bioinspired Materials using polymer chemistry, Decellularized Extracellular Matrix , and 3D Bioprinting to engineer Cell Microenvironments for therapeutic applications. Recent Publications highlight advancements in Human-Derived Hydrogels , Photopolymerizable Scaffolds , Magneto-Responsive Biomaterials , and Programmable Bioinks . Trends show emphasis on Organ-on-a-Chip integration, Smart Living Materials , and Green Bioprinting methodologies. Scientific Awards include: European Research Council Advanced Grants (2015, 2020) Fellow at IUPAC, European Academy of Sciences, and American Institute of Medical and Biological Engineering ERC Proof of Concept Grants Doctor Honoris Causa from University of Lorraine and Utrecht UNESCO Chair on Biomaterials George Winter Award (European Society for Biomaterials) Supervisions & Collaborations encompass 74+ MSc, 26+ PhD students, and 40+ postdocs. He co-founded METATISSUE and CELLULARIS Biomodels , and serves as Editor-in-Chief of Materials Today Bio .

Betsy Foxmanمشاهده پروفایل

استاد

• Infectious Disease Epidemiology
• Human Microbiome Research
• Antibiotic Resistance
• +۵ مورد دیگر

Betsy Foxman serves as the Hunein F. and Hilda Maassab Professor of Epidemiology at the University of Michigan School of Public Health. She directs three major initiatives: the Center for Molecular and Clinical Epidemiology of Infectious Diseases, the Integrated Training in Microbial Systems program, and the Certificate in Healthcare Infection Prevention & Control. Her academic leadership spans decades with continuous research contributions. Dr. Foxman earned her PhD and MSPH from UCLA (1983, 1980) and BS from UC Berkeley (1977). Her research centers on infectious disease transmission, microbiome ecology, antibiotic resistance, and wastewater surveillance . Key projects include analyzing the oral microbiome in dental caries using genomic methods, studying nose/throat microbiome associations with respiratory infections in nursing facilities, and developing wastewater monitoring for antibiotic-resistant pathogens. Her work integrates next-generation sequencing with epidemiological analysis to identify novel interventions. Publication trends reveal consistent focus on microbiome-pathogen interactions across multiple body sites (oral, vaginal, gut, respiratory). Recent articles demonstrate methodological innovation in wastewater epidemiology (2024 Norovirus GII monitoring) and clinical applications like predicting vancomycin-resistant enterococci contamination (2023 Lancet study). Her research bridges molecular microbiology with population health, emphasizing translational potential for diagnostics and public health interventions. Fellow of the Infectious Disease Society of America Fellow of the American College of Epidemiology Fellow of the American Academy of Microbiology Dr. Foxman's advising portfolio includes numerous NIH-funded projects on microbiome dynamics and infection control. Her leadership in the Center for Molecular and Clinical Epidemiology drives collaborative research across departments. Current initiatives focus on wastewater surveillance standardization and microbiome-based diagnostics for infection prevention. She maintains active laboratories for genomic analysis of microbial communities and clinical sample processing.

Horst A. von Recumمشاهده پروفایل

استاد

• Drug Delivery Systems
• Biomedical Engineering
• Stem Cell Differentiation
• +۴ مورد دیگر

Horst A. von Recum, PhD, is the Executive Vice Chair of the Case School of Engineering and a Professor in the Department of Biomedical Engineering at Case Western Reserve University. He is also a member of the Cancer Imaging Program at the Case Comprehensive Cancer Center. His research focuses on developing novel platforms for molecular and cellular delivery, including affinity-based systems for controlled drug release and directed stem cell differentiation. Key applications include HIV therapies, wound healing, ocular disease treatments, and tissue engineering. His work emphasizes improving drug delivery precision through molecular interactions and enhancing stem cell viability for therapeutic use. Dr. von Recum’s research interests span drug delivery systems, biomaterials science, and regenerative medicine. His lab explores cyclodextrin polymers for sustained antibiotic release, affinity-driven drug refilling mechanisms, and engineering biocompatible materials to combat implant-related infections. Recently, his team has investigated microbiome interactions with neural implants and developed polymer-based solutions for localized chemotherapy. Notable contributions include advancements in PMMA bone cement composites for drug refillable depots, cyclodextrin hydrogels for controlled release, and affinity-based systems for anti-fibrotic treatments. His work bridges materials science with clinical applications, addressing challenges in orthopedic infections, neural interfaces, and cardiovascular regeneration. Scientific achievements include over 100 peer-reviewed publications. Research funding has supported projects on antimicrobial coatings, drug delivery mechanics, and stem cell differentiation. Dr. von Recum collaborates across disciplines to translate biomaterial innovations into clinical solutions.

• Veterinary Epidemiology
• Antimicrobial Resistance
• Infectious Disease Surveillance
• +۳ مورد دیگر

Lorin D. Warnick is currently serving as the Austin O. Hooey Dean of Veterinary Medicine at Cornell University College of Veterinary Medicine. He is a tenured Professor in the Department of Population Medicine and Diagnostic Sciences, where his research focuses on the epidemiology of Salmonella infections and antimicrobial resistance in enteric bacteria affecting both domestic animals and humans. A key contributor to Cornell's response to the COVID-19 pandemic, he has led research on SARS-CoV-2 diagnostic testing and campus outbreak dynamics. Education : B.S. in Microbiology (1984) from Brigham Young University DVM (1988) from Colorado State University Ph.D. in Veterinary Medicine (Epidemiology) and Statistics from Cornell University (1994) Professional Experience : Assistant Professor (1994-1996) at Virginia-Maryland Regional College of Veterinary Medicine Assistant/Associate Professor (1996-2008) and Professor (2008-present) at Cornell University Section Chief in Ambulatory and Production Medicine (1997-1999) Research Interests span veterinary epidemiology, antimicrobial resistance, foodborne pathogens, and public health. His work connects animal and human health through One Health frameworks, particularly in Salmonella transmission dynamics between dairy cattle and humans. He has pioneered surveillance systems for infectious diseases, including the model used during Cornell's COVID-19 response. Scientific Awards include: Phi Zeta Veterinary Honor Society (1987) Phi Kappa Phi Honor Society (1988) Honorary Diploma from American Veterinary Epidemiology Society (2018) One Cornell Award for Leadership in Pandemic Testing (2021) Advising and Grants highlight his role in mentoring students and leading interdisciplinary research teams. His grants focus on antimicrobial resistance mitigation, dairy calf health, and pandemic response infrastructure. He has collaborated extensively with institutions like USDA and CDC on foodborne disease research. Labs and Collaborations include leadership in Cornell's Veterinary Diagnostic Laboratories and contributions to the American College of Veterinary Preventive Medicine. His work integrates epidemiological modeling, microbiome analysis, and policy development for sustainable agricultural practices.

• Metabolomics
• Antibiotic Resistance
• Biotechnology
• +۵ مورد دیگر

Per Bruheim is a Professor at the Department of Biotechnology and Food Science, Norwegian University of Science and Technology (NTNU). He leads the Bruheim research group, focusing on Deep Phenotyping of prokaryotic and eukaryotic systems using advanced metabolomics, fluxomics, and lipidomics techniques. He is the scientific leader of the NV faculty Mass Spectrometry lab and has developed targeted/non-targeted MS methods applied to diverse biological systems. Teaching roles include leading the 2-year and 5-year Biotechnology programs (MSBIOTECH and MBIOT5). He teaches courses such as TBT4140 Biochemical Engineering, TBT4110 Microbiology, and TKP4170 Process Design. Current research projects include targeting antibiotic resistance via bacterial stress responses (Trond Mohn Foundation), chemically defined cell culture media development, and peptide drug inhibition of translesion synthesis mechanisms. Research interests center on metabolomics and systems biology approaches to study microbial physiology and antibiotic resistance, with applications in bioprocessing and sustainable protein production. His lab employs mass spectrometry for precise metabolic profiling and collaborates internationally on projects involving lipidomics and flux analysis. Advising and grants involve mentoring over a dozen master’s theses on topics like microbial fermentation optimization, single-cell protein production, and recombinant protein expression. He actively pursues funding for projects addressing AMR mechanisms and bioprocess innovation. The Bruheim group also collaborates with industry on sustainable raw material utilization for microbial cultures. Labs/Teams: Leads the Mass Spectrometry facility at NTNU and directs the Bruheim research group within the Institute of Biotechnology (IBT). Collaborates with national/international partners in microbiology, metabolomics, and bioprocessing.

• Sepsis
• Innate Immunity
• Neonatal Immunology
• +۵ مورد دیگر

Andrew Currie is a Professor and Associate Dean (Research & Innovation) at Murdoch University's School of Medical, Molecular and Forensic Sciences, within the College of Environmental and Life Sciences. He leads the Sepsis Diagnostics Research Group at the Centre for Molecular Medicine and Innovative Therapeutics and co-heads the Neonatal Infection and Immunity Team with Clinical Professor Tobias Strunk at the Wesfarmers Centre of Vaccine & Infectious Diseases at Telethon Kids Institute. His research focuses on immunology and infectious diseases in pediatric populations, particularly sepsis diagnostics and neonatal immunity. Education: PhD (Immunology, University of Western Australia, 2001); BSc (Biotechnology with Honors, Murdoch University, 1997). Research Interests: Sepsis diagnostics, innate immunity mechanisms in neonates, medical biotechnology for diagnostics (e.g., biosensors), and translational research in pediatric infections. Collaborates internationally with institutions in Canada, Denmark, the UK, US, and China. Aims to reduce sepsis burden in vulnerable populations through advanced molecular methods and interdisciplinary partnerships. Key Affiliations: Lead of Sepsis Diagnostics Research Group (Murdoch University), Senior Lecturer in Immunology, Honorary Associate at Kids Research Institute Australia. Past roles include leadership in the Centre for Molecular Medicine and Innovative Therapeutics. Scientific Contributions: Over 100 peer-reviewed articles focusing on sepsis biomarkers, neonatal immunity, tick-borne diseases, and clinical trials for interventions like vitamin C and probiotics in critical illness. Active in developing precision medicine approaches for neonatal sepsis. Grants & Funding: Co-leads major projects on sepsis diagnostics and neonatal infection, supported by national and international grants. Collaborates on multi-institutional initiatives. Labs/Teams: Sepsis Diagnostics Research Group (Murdoch) and Neonatal Infection and Immunity Team (Telethon Kids Institute). Works closely with the Personalised Medicine Centre and Health Futures Institute.

• Biomedical Engineering
• Drug Delivery Systems
• Microfluidics
• +۶ مورد دیگر

Dario Carugo is an Associate Professor of Biostimulation and Immunological Engineering at University College London (UCL), School of Pharmacy, Department of Pharmaceutics. Previously, he held positions at the University of Oxford (Botnar Research Centre) and University of Southampton. His academic foundation includes a BSc and MSc in Biomedical Engineering from Politecnico di Milano (specializing in Biological Fluid Dynamics & Bio-Machines), and a PhD in Bioengineering Sciences from the University of Southampton. His research spans acoustofluidics , microfluidic drug delivery systems , and biofilm eradication technologies . Key interests include ultrasound-activated drug carriers, mechanistic models for therapeutic physical stimuli, and nano/micro-scale systems for chronic wound treatment, implant infections, and musculoskeletal disorders. His work integrates computational fluid dynamics with experimental models to optimize interventional treatments. Recent publications (2023-2025) reveal a strong trend toward biofilm-targeted therapies using ultrasound-responsive carriers (microbubbles/nanodroplets), oxygen delivery systems for bone healing, and 3D-printed devices for precision drug delivery. Interdisciplinary collaborations span microbiology, urology, and tissue engineering, with emphasis on translating lab innovations to clinical applications for chronic wounds and implant-associated infections. Awards: Italian National Bioengineering Group award IMechE Biomedical Engineering Division award EPSRC Doctoral Prize award FP7 European project funding BBSRC award Junior Research Fellowship at Jesus College, Oxford Carugo teaches Biofluids (Engineering Science) and Micro- & nano-technologies for personalised medicine (MSc Pharmacology), alongside supervising MSc Musculoskeletal Sciences laboratory activities. His Botnar Research Centre lab pioneers vortical flow devices for ultrasound-activated drug delivery and high-speed imaging systems (>1 million fps) to quantify cellular responses to mechanical stimuli.

Mathangi Gopalakrishnanمشاهده پروفایل

دانشیار

• Pharmacometrics
• Precision Therapeutics
• Predictive Analytics
• +۹ مورد دیگر

Mathangi Gopalakrishnan, PhD, MPharm, is an Associate Professor in the Department of Practice, Science, and Health Outcomes Research at the University of Maryland School of Pharmacy. She is actively engaged in research, mentoring, and academic scholarship, with a focus on quantitative clinical pharmacology and data-driven therapeutic optimization. Education: PhD, Statistics, University of Maryland, Baltimore County MS, Statistics, University of Maryland, Baltimore County MPharm, Birla Institute of Technology & Science, Pilani, Rajasthan, India BPharmacy (Honors), Birla Institute of Technology & Science, Pilani, Rajasthan, India Her research interests center on pharmacometrics, precision therapeutics, predictive analytics, real-world data, and drug development . She integrates principles of clinical pharmacology, advanced frequentist and Bayesian statistical methods, and artificial intelligence/machine learning to enhance patient outcomes, particularly among vulnerable populations. Her lab's work includes designing prospective clinical pharmacokinetic trials for anti-epileptics and antimicrobials in patients on continuous renal replacement therapy, leveraging real-world data from electronic health records to optimize dosing in neonatal opioid withdrawal syndrome and pediatric anticoagulation, and developing models for disease progression in conditions like schizophrenia and binge-eating disorders. The trends in her recent publications reflect a consistent focus on model-informed precision dosing, real-world evidence generation, pharmacokinetic-pharmacodynamic (PK/PD) modeling in special populations, and methodological innovation in clinical trial design . Her work spans diverse therapeutic areas including critical care, neonatology, psychiatry, and maternal health, demonstrating a broad impact of quantitative pharmacology. Dr. Gopalakrishnan is accepting applications for postdoctoral positions in pharmacometrics at the Center for Translational Medicine, indicating active research funding and team leadership. Her collaborations extend to academic medical institutions nationwide, underscoring her role in multi-center research initiatives. She is involved in collaborative research with academic medical institutions across the country and has presented her work at major conferences including the Joint Statistical Meetings (JSM) and the American Conference on Pharmacometrics (ACoP).

• Veterinary Epidemiology
• Antimicrobial Resistance
• One Health
• +۳ مورد دیگر

Professor Ruth Zadoks is a faculty member at the Sydney School of Veterinary Science, University of Sydney. She holds academic positions in the Sydney Institute of Agriculture and Sydney Southeast Asia Centre, and is involved with the Sydney Infectious Diseases Institute. Her research focuses on antimicrobial resistance, zoonotic diseases, bovine health, and One Health principles. Notable projects include investigations into Japanese encephalitis transmission dynamics, antibiotic use in East African livestock, and molecular epidemiology of Group B Streptococcus. Recent grants include studies on microbial spillover in aquaculture and precision feeding in broiler chickens. Her work integrates veterinary and public health perspectives, addressing issues like anthrax impacts in rural Africa, tilapia-borne zoonoses, and diagnostic innovations for bovine mastitis. Over 118 peer-reviewed publications highlight her contributions to aquatic pathogen genomics, food safety, and livestock disease ecology. Recent grants (2024): - Revealing microbial spillover drivers in aquaculture (SSEAC Incubator) - Sustainable Precision Feeding in Broiler Chickens (AgriFutures) - ASEAN Antimicrobial Resistance Network (DFAT-funded) Labs/Teams: Affiliated with Sydney Infectious Diseases Institute and collaborates across interdisciplinary One Health networks.

Amarjeet Bassiمشاهده پروفایل

استاد

• Micro-algal applications
• Water treatment and refining
• Nutrient recovery
• +۵ مورد دیگر

Dr. Amarjeet Bassi is a Professor of Chemical and Biochemical Engineering in the Faculty of Engineering at Western University. He holds a Ph.D. and is a Professional Engineer (P.Eng). His research group has made significant contributions to environmental engineering, particularly in developing the world's first circulating fluidized bed ion exchange chromatography system. Dr. Bassi has established strong industry partnerships, including with Renix Inc. for commercializing his UIX technology and with Stanton Farms for phycoremediation research. Dr. Bassi's research interests focus on innovative environmental and bio-separation technologies. His work spans micro-algal applications for clean water and value recovery, integrated technologies for water refining and nutrient and energy recovery using biological systems, bio-separations, and biosensors. His research group pioneered the circulating fluidized bed ion exchange chromatography system (UIX), which is now being commercialized by Renix Inc. He has also developed significant expertise in phycoremediation, particularly for treating wastewater from dairy farms and greenhouse industries. Dr. Bassi's publication record demonstrates a strong focus on sustainable water treatment technologies, bioenergy production, and biodegradation of plastics. His recent work shows increasing attention to microplastic pollution, hydrothermal liquefaction of microalgae for bio-crude oil production, and innovative approaches to wastewater treatment using microbial systems and phycoremediation. Distinguished Speaker Award from IChE (2007) Engineering Science Prize for Outstanding Teaching at Western University (2000) SPIE Optics East Best Paper Award (2006) Dr. Bassi has graduated over 45 highly qualified personnel (PhDs, M.E.Sc and PDFs/Research Associates) and supervised more than 50 undergraduate research students. His research has been supported by significant grants from Canada Foundation for Innovation, NSERC Strategic Project grants, OMAFRA New Directions, and other funding agencies. He has served in leadership roles including President of the Canadian Society for Chemical Engineering (2014-2015) and as Associate Editor for the Canadian Journal of Chemical Engineering. Dr. Bassi leads an active research group focusing on innovative environmental technologies. His lab has developed the world's first circulating fluidized bed ion exchange chromatography system and has established successful industry partnerships, particularly with Renix Inc. for commercializing the UIX technology. His research group maintains strong collaborations with Stanton Farms for phycoremediation research and works with various industry partners on wastewater treatment and bioenergy projects.